Oak Ridge Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$77M Sell
64,184
-1,966
-3% -$2.01M 4.36% 5
2026
Q1
$60.8M Buy
66,150
+368
+0.6% +$373K 4.02% 7
2025
Q4
$70.7M Buy
65,782
+4,934
+8% +$4.72M 4.28% 7
2025
Q3
$46.4M Buy
60,848
+1,433
+2% +$1.07M 3% 8
2025
Q2
$46.3M Buy
59,415
+802
+1% +$623K 3.32% 7
2025
Q1
$48.4M Buy
58,613
+3,370
+6% +$2.8M 4.03% 6
2024
Q4
$42.6M Buy
55,243
+3,201
+6% +$2.65M 3.35% 7
2024
Q3
$46.1M Buy
52,042
+3,646
+8% +$3.28M 4.02% 5
2024
Q2
$43.8M Sell
48,396
-7,207
-13% -$5.77M 4.17% 5
2024
Q1
$43.3M Buy
55,603
+2,030
+4% +$1.44M 4.37% 5
2023
Q4
$31.2M Buy
53,573
+776
+1% +$453K 3.59% 5
2023
Q3
$28.4M Buy
52,797
+1,503
+3% +$774K 3.62% 5
2023
Q2
$24.1M Sell
51,294
-848
-2% -$356K 2.97% 5
2023
Q1
$17.9M Sell
52,142
-231
-0.4% -$77.9K 2.42% 5
2022
Q4
$19.2M Sell
52,373
-2,336
-4% -$828K 2.85% 4
2022
Q3
$17.7M Sell
54,709
-2,231
-4% -$707K 2.68% 4
2022
Q2
$18.5M Sell
56,940
-1,778
-3% -$534K 2.69% 5
2022
Q1
$16.8M Sell
58,718
-3,561
-6% -$916K 1.87% 10
2021
Q4
$17.2M Sell
62,279
-1,690
-3% -$428K 1.45% 12
2021
Q3
$14.8M Sell
63,969
-980
-2% -$242K 1.3% 16
2021
Q2
$14.9M Sell
64,949
-1,146
-2% -$230K 1.3% 14
2021
Q1
$12.3M Buy
66,095
+182
+0.3% +$35.6K 1.15% 17
2020
Q4
$11.1M Sell
65,913
-24,774
-27% -$3.7M 0.98% 27
2020
Q3
$13.4M Sell
90,687
-1,490
-2% -$231K 1.04% 24
2020
Q2
$15.1M Sell
92,177
-1,551
-2% -$238K 1.27% 18
2020
Q1
$13M Sell
93,728
-8,071
-8% -$1.11M 1.33% 16
2019
Q4
$13.4M Sell
101,799
-6,252
-6% -$725K 0.98% 36
2019
Q3
$12.1M Sell
108,051
-4,141
-4% -$461K 0.91% 46
2019
Q2
$12.4M Sell
112,192
-8,293
-7% -$977K 0.86% 44
2019
Q1
$15.6M Sell
120,485
-2,284
-2% -$278K 0.99% 30
2018
Q4
$14.2M Sell
122,769
-1,724
-1% -$193K 1.02% 29
2018
Q3
$13.4M Sell
124,493
-6,260
-5% -$626K 0.74% 52
2018
Q2
$11.2M Sell
130,753
-3,922
-3% -$322K 0.63% 63
2018
Q1
$10.4M Sell
134,675
-54,641
-29% -$4.4M 0.58% 70
2017
Q4
$16M Sell
189,316
-7,800
-4% -$664K 0.76% 52
2017
Q3
$16.9M Sell
197,116
-20,401
-9% -$1.67M 0.69% 62
2017
Q2
$17.9M Buy
217,517
+10,888
+5% +$888K 0.57% 67
2017
Q1
$17.4M Buy
206,629
+34,845
+20% +$2.79M 0.58% 66
2016
Q4
$12.6M Sell
171,784
-78,090
-31% -$5.82M 0.41% 64
2016
Q3
$20.1M Sell
249,874
-3,844
-2% -$308K 0.52% 64
2016
Q2
$20M Sell
253,718
-11,257
-4% -$847K 0.51% 61
2016
Q1
$19.1M Buy
264,975
+36,328
+16% +$2.75M 0.48% 65
2015
Q4
$19.3M Buy
228,647
+2,111
+0.9% +$175K 0.46% 67
2015
Q3
$19M Buy
+226,536
New +$19.1M 0.45% 66

Other funds holding LLY

Oak Ridge Investments's LLY Position: Q2 2026 in Review

Oak Ridge Investments reduced its Eli Lilly (LLY) stake by 3% in Q2 2026, selling an estimated $2.01M and leaving 64,184 shares worth $77M. The position accounts for 4.36% of the portfolio, ranked #5.

Oak Ridge Investments first reported a position in LLY in Q3 2015 and has held it in 44 quarters since. 1,435 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Oak Ridge Investments held 64,184 shares of Eli Lilly worth $77M as of Q2 2026.
  • Oak Ridge Investments sold 1,966 Eli Lilly shares in Q2 2026, an estimated $2.01M.
  • Eli Lilly made up 4.36% of Oak Ridge Investments's portfolio in Q2 2026, its #5 holding.
  • Oak Ridge Investments first reported a position in Eli Lilly in Q3 2015 and has held it in 44 quarters since.
  • 1,435 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Oak Ridge Investments's 13F filing for Q2 2026, filed 21 Jul 2026.